CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,698 | $320.99 | $545K | 98,199 |
| 2026-08-10 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −6,517 | $321.53 | $2.1M | 197,257 |
| 2026-08-10 | Sheena Jonathan Director | Sale 10b5-1 | −6,000 | $325.32 | $2.0M | 230,464 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $308.40 | $31K | 245,514 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −400 | $310.23 | $124K | 245,114 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −400 | $311.88 | $125K | 244,714 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −900 | $313.07 | $282K | 243,814 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −850 | $314.25 | $267K | 242,964 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −600 | $315.32 | $189K | 242,364 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −5,111 | $316.61 | $1.6M | 237,253 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $317.97 | $64K | 237,053 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $318.63 | $32K | 236,953 |
| 2026-08-07 | Sheena Jonathan Director | Sale 10b5-1 | −489 | $320.90 | $157K | 236,464 |
| 2026-08-07 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −2,000 | $320.90 | $642K | 2,000 |
| 2026-08-06 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award 10b5-1 | +20,000 | 203,774 | ||
| 2026-08-04 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −478 | $274.22 | $131K | 51,637 |
| 2026-08-03 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −295 | $267.99 | $79K | 183,774 |
| 2026-08-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −410 | $267.99 | $110K | 132,019 |
| 2026-08-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −300 | $259.98 | $78K | 131,719 |
| 2026-08-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −200 | $261.49 | $52K | 131,519 |
Page 10 of 39 · 767 trades